Continuing our support of the diabetes community during the pandemic
Bigfoot Biomedical is founded on the principle of harnessing technology to ease the burden for people living with diabetes and their caregivers.
And amid the coronavirus health crisis, we’re continuing to apply technology to ensure our important work never misses a beat.
Our mission remains urgent, and we will overcome these unprecedented events to bring solutions like Bigfoot Unity to 510(K) submission as fast as we possibly can. We’re in this together, and we’re in it for you!
The Bigfoot team includes many individuals with type 1 and type 2 diabetes and caregivers. Like you, we’re accessing resources to help understand the impact of this health crisis on people with diabetes. Here are a few that have been helpful to our team.
The Centers for Disease Control provides the latest public health and safety information regarding COVID-19.
Medicare - Medicare has temporarily expanded its coverage of telehealth services so people with diabetes can visit with their health care provider from home.
Bigfoot Biomedical was founded by people affected by and living with Type 1 Diabetes (T1D) and is committed to leveraging data, people, and smart technology to create a connected ecosystem of solutions that will deliver improved outcomes valued by patients, providers, and payers.
Bigfoot's investigational automated insulin delivery system, otherwise known as an "artificial pancreas," was inspired by a proof-of-concept system that's been used for over 50,000 hours.
1820 McCarthy Blvd
Milpitas, CA 95035
Phone: 408-716-5600
info@bigfootbiomedical.com
FAQ
Privacy Policy
Terms of Use
Site Map
iPhone® is a registered trademark of Apple Inc.